CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knowles, T. T.
Right arrow Articles by Bélanger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knowles, T. T.
Right arrow Articles by Bélanger, M.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2003, p. 520-524, Vol. 10, No. 4
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.4.520-524.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Characterization of the Major Antigenic Protein 2 of Ehrlichia canis and Ehrlichia chaffeensis and Its Application for Serodiagnosis of Ehrlichiosis{ddagger}

Tamece T. Knowles,1 A. Rick Alleman,2* Heather L. Sorenson,2 David C. Marciano,1 Edward B. Breitschwerdt,3 Shimon Harrus,4 Anthony F. Barbet,1 and Myriam Bélanger1,{dagger}

Departments of Pathobiology,1 Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida 32610,2 Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606,3 School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel 761004

Received 11 September 2002/ Returned for modification 27 November 2002/ Accepted 11 March 2003


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Canine monocytic ehrlichiosis, caused by Ehrlichia canis or Ehrlichia chaffeensis, can result in clinical disease in naturally infected animals. Coinfections with these agents may be common in certain areas of endemicity. Currently, a species-specific method for serological diagnosis of monocytic ehrlichiosis is not available. Previously, we developed two indirect enzyme-linked immunosorbent assays (ELISAs) using the major antigenic protein 2 (MAP2) of E. chaffeensis and E. canis. In this study, we further characterized the conservation of MAP2 among various geographic isolates of each organism and determined if the recombinant MAP2 (rMAP2) of E. chaffeensis would cross-react with E. canis-infected dog sera. Genomic Southern blot analysis using digoxigenin-labeled species-specific probes suggested that map2 is a single-copy gene in both Ehrlichia species. Sequences of the single map2 genes of seven geographically different isolates of E. chaffeensis and five isolates of E. canis are highly conserved among the various isolates of each respective ehrlichial species. ELISA and Western blot analysis confirmed that the E. chaffeensis rMAP2 failed to serologically differentiate between E. canis and E. chaffeensis infections.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Canine monocytic ehrlichiosis, caused by Ehrlichia canis, is a debilitating tick-borne disease that has been reported throughout the United States and most of the world. Infection with E. canis may result in extensive morbidity and mortality (18). Nonspecific clinical and hematological abnormalities, such as dyspnea, anemia, leukopenia, and thrombocytopenia, are often observed during E. canis infections (14). Infection with Ehrlichia chaffeensis, the causative agent of human monocytic ehrlichiosis, is also known to occur in dogs (14). Although natural infections with E. chaffeensis have been observed in dogs with clinical findings consistent with ehrlichiosis, a causal relationship has not been clearly established (5).

The immunofluorescent-antibody (IFA) test is the method most widely used to diagnose E. chaffeensis and E. canis infections and is generally considered to be the "gold standard" for serologic diagnosis (20). However, the results are often subjective and nonspecific due to cross-reacting epitopes between species (5, 19). In addition, the IFA test is time-consuming, requires cultivation and purification of the whole organism, and cannot test multiple samples simultaneously. The use of recombinant proteins may improve test specificity because of a lack of cross-reaction with proteins common to several species of organisms, such as heat shock proteins (20).

There have been several reports evaluating recombinant antigenic proteins for the diagnosis of E. canis and E. chaffeensis infections including P28 (22) and P120 (21) of E. chaffeensis and P30 (16) and P43 (15) of E. canis. Some of these antigens have been shown to contain species-specific epitopes (15, 21, 23). Recently, the recombinant major antigenic protein 2 (rMAP2) of E. canis and that of E. chaffeensis were evaluated to determine the potential of each as a serodiagnostic test antigen (1, 2). Both assays were able to accurately distinguish E. canis-infected dogs from noninfected and E. chaffeensis-infected people from noninfected people.

The map2 genes of E. canis and E. chaffeensis have significant homology to the map2 of Ehrlichia ruminantium (4) and the msp5 of Anaplasma marginale (17). The map2 of E. ruminantium and the msp5 of A. marginale have been shown to be single-copy genes that are highly conserved among the geographically different isolates of each respective species (4, 17).

In this study, we further characterize the MAP2s of E. canis and E. chaffeensis to define MAP2’s suitability as a diagnostic test antigen by determining if the protein is encoded by a single-copy gene and if this gene is highly conserved within each species. In addition, the E. canis rMAP2 enzyme-linked immunosorbent assay (ELISA) showed no cross-reactivity when serum from dogs infected with Anaplasma platys, Ehrlichia ewingii, Neorickettsia risticii, Rickettsia rickettsii, Bartonella vinsonii, Mycoplasma haemocanis, and Neospora caninum was tested (2). However, cross-reactivity studies using the rMAP2s of E. canis and E. chaffeensis have not been performed. In this study, we also evaluate the potential for serologically distinguishing between E. canis and E. chaffeensis infections using the rMAP2.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Origins and cultivation of E. chaffeensis and E. canis isolates. Chromosomal DNA from four canine E. canis isolates was used (Florida, DJ [North Carolina; 5], Jellybean [Virginia], and Israel no. 611 [13]). Three human E. chaffeensis isolates from Florida, but from different counties (Wakulla, Liberty, and Osceola), were obtained from Roman Reddy (Kansas State University, Manhattan, Kans.). DNA from three canine E. chaffeensis cases from North Carolina (Shasta, Cherokee, and Jack) (5) was also used. E. chaffeensis Wakulla, Liberty, and Osceola were cultivated in the DH82 canine macrophage cell line in Eagle's minimum essential medium containing 2 mM L-glutamine and 10% fetal bovine serum at 37°C with 5% CO2 (9). E. canis Oklahoma was cultivated as previously described (2). Uninfected DH82 cells were cultivated under the same conditions as those for the infected macrophages.

Ehrlichia purification and DNA preparation. DH82 cells containing either E. chaffeensis or E. canis were harvested at 90 to 100% infectivity and purified by differential centrifugation as previously described (8). Briefly, the organisms were purified from host cell components by centrifugation through 15% meglumine diatrizoate and diatrizoate sodium (RenoCal-76; Bracco Diagnostics, Inc., Princeton, N.J.) in phosphate-buffered saline (PBS; 5.2 mM KH2PO4, 8.1 mM Na2HPO4, 116 mM NaCl [pH 7.0]) at 22,000 x g for 20 min. Final pellets were resuspended in buffer 1 from the Qiagen, Inc. (Valencia, Calif.) genomic DNA buffer set containing 100 µg of RNase/ml. Genomic DNAs of purified E. chaffeensis and E. canis, as well as DNA from uninfected DH82 cells, were purified with the Qiagen genomic DNA purification kit according to the manufacturer's instructions.

PCR amplification and cloning of the map2 genes. Target DNA (10 to 200 ng) was amplified with 2.5 U of cloned Pfu polymerase (Stratagene, La Jolla, Calif.) in a mixture containing a 0.5 µM concentration of each appropriate primer, 2 mM deoxynucleoside triphosphates, 200 mM Tris-HCl (pH 8.8), 100 mM KCl, 100 mM (NH4)2SO4, 1% Triton X-100, and 1 mg of nuclease-free bovine serum albumin (BSA)/ml. PCR amplification of the map2 genes from E. chaffeensis was performed with primers AB620 and AB623 (4) under the following conditions: 94°C for 5 min; 30 cycles of denaturing at 93°C for 30 s, annealing at 45°C for 1 min, and extension at 72°C for 2.5 min; and a final elongation step at 72°C for 10 min. Amplification of the E. canis map2 gene was performed as previously described (1) with primers AB620 and AB624 (4). Amplicons were analyzed by gel electrophoresis on a 1% agarose gel in 1x TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM disodium EDTA). The High Pure PCR purification kit (Roche Molecular Biochemicals, Indianapolis, Ind.) was used to purify PCR products for E. canis (Florida, Israel no. 611, DJ, and Jellybean isolates) and E. chaffeensis (Liberty isolate) prior to sequencing. Taq DNA polymerase (Sigma Chemical Co., St. Louis, Mo.) was added to the E. chaffeensis Wakulla and Osceola PCR mixtures, followed by a 10-min incubation at 72°C, to prepare the amplicon for ligation into the pCR2.1 TOPO TA vector (Invitrogen Corporation, Carlsbad, Calif.) by the addition of an A residue to the 3' ends. The altered 1.3-kb amplicon was electrophoresed on a 1% low-melting-point agarose gel. The desired band was extracted and melted at 65°C. The amplicon was ligated into the pCR2.1 TOPO TA vector by following the manufacturer's instructions and transformed into competent Escherichia coli (One Shot cells; Invitrogen Corp.). Transformants were grown on Luria-Bertani (LB) agar plates containing ampicillin (50 µg/ml) and 40 µg of 5-bromo-4-chloro-3-indolyl-ß-D-galactoside/ml overnight. Blue and white selection was used to select colonies with an insert. White colonies were selected and incubated in LB broth with ampicillin (50 µg/ml) overnight at 37°C. Plasmids were recovered and purified with the Qiagen plasmid purification kit. Plasmids were digested with EcoRI and analyzed on agarose gel prior to sequencing.

DNA sequencing and analysis. The DNA sequences of both strands of the 1.3-kb inserts of the pCR2.1 TOPO TA vector and of the purified PCR products were determined by the DNA Sequencing Core Laboratory (Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville). Sequences were analyzed with UNIX and SeqWeb Genetics Computer Group (GCG) programs (University of Wisconsin, Madison) and aligned by the Pile-up method.

Southern blot analysis. Digoxigenin (DIG)-labeled DNA probes were generated by PCR amplification of the map2 gene by using purified DNA from E. chaffeensis clone K1 (1) and E. canis clone 8a (2). Primers ARA3 and ARA4 were used for E. chaffeensis (1), and ARA5 and ARA6 were used for for E. canis (2). Genomic DNA of E. chaffeensis (Wakulla) or E. canis (Oklahoma) as well as control DH82 DNA (1 to 2 µg) was digested with restriction enzymes BamHI, EcoRI, ClaI, and VspI for 1 h at 37°C. The purified unlabeled PCR product (600 bp) from E. chaffeensis clone K1 or E. canis clone 8a was used as a positive control. The digested DNA was electrophoresed on a 1% agarose gel, transferred to a positively charged nylon membrane (Boehringer Mannheim, Indianapolis, Ind.) by capillary transfer, and hybridized with a map2 DIG-labeled probe diluted in a mixture containing 5x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 2% blocking solution, 0.1% N-lauroylsarcosine, 50% formamide, and 0.02% sodium dodecyl sulfate (SDS) hybridization solution. Hybridization was performed overnight at 37°C under low-stringency conditions. The membrane was washed twice for 5 min at room temperature in 2x SSC-0.1% SDS and twice for 15 min at 37°C in 0.5x SSC-0.1% SDS. The hybridized probes were detected with chemiluminescence and exposed to Hyperfilm (Amersham International plc, Little Chalfont, Buckinghamshire, England) at room temperature.

Sera. Twenty-five serum samples from the College of Veterinary Medicine, North Carolina State University, Raleigh, and the College of Veterinary Medicine, University of Florida, Gainesville, were tested for antibodies against the rMAP2 of E. canis and E. chaffeensis. Five of the 25 samples were IFA-negative sera from clinically healthy dogs during well-patient visits or preinfected sera from experimentally infected dogs. The remaining 20 samples were IFA positive. Eighteen of the IFA-positive samples were obtained from dogs experimentally infected with E. canis in a previous study performed at North Carolina State University (6). Two of the IFA-positive samples were obtained from naturally infected dogs that presented clinical signs consistent with canine ehrlichiosis. E. chaffeensis IFA-positive human serum was used as a positive control for the E. chaffeensis rMAP2. This sample was obtained from an individual with a history of tick exposure and clinical and laboratory findings consistent with human monocytic ehrlichiosis (1). A horseradish peroxidase (HRP)-labeled antihistidine antibody [anti-His (C-term)-HRP; Invitrogen Co.] was used as a positive control for the rMAP2 immunoblotting.

E. canis and E. chaffeensis rMAP2 production and purification. Production, purification with imidazole and pH elution buffer (20 mM NaPO4, 500 mM NaCl [pH 4.0]), and analysis by SDS-polyacrylamide gel electrophoresis of the rMAP2s of E. canis and E. chaffeensis were performed as previously described (1).

Indirect ELISA for cross-reactivity analysis. ELISAs were performed as previously described with purified rMAP2 from E. canis or E. chaffeensis as the test antigen (1, 2). Briefly, each well of polystyrene microtiter plates (Maxi Sorp; Nunc, Roskilde, Denmark) was coated with 100 µl of purified rMAP2 of E. canis or E. chaffeensis (2 µg/ml) in 0.05 M carbonate-bicarbonate buffer (pH 9.6; Sigma Chemical Co.), and microtiter plates were incubated overnight at 4°C. The wells were then washed four times with wash buffer containing 1x PBS and 0.5% (vol/vol) Tween 20 and blocked for 60 min at room temperature with 1% (wt/vol) bovine serum albumin in 1x PBS. The plates were washed four times as described above and incubated for 60 min at room temperature with test sera. Samples from 18 dogs experimentally infected with E. canis were tested simultaneously and in triplicate at a dilution of 1/300, with each rMAP2 as the antigen. Uninfected canine serum was used as a negative control for the E. canis rMAP2 ELISA. Uninfected human serum and serum from an E. chaffeensis-infected individual were used as negative and positive controls, respectively, for the E. chaffeensis rMAP2 ELISA. Alkaline phosphatase-conjugated goat anti-human immunoglobulin G (whole molecule; Sigma Chemical Co.) or alkaline phosphatase-conjugated rabbit anti-dog immunoglobulin G (whole molecule; Sigma Chemical Co.) was used as the secondary antibody at a dilution of 1:5,000 in 1% (wt/vol) BSA in 1x PBS with the substrate p-nitrophenylphosphate (1 mg/ml; Sigma Chemical Co.). Absorbance at 405 nm was measured with a Rainbow plate reader (Tecan U.S. Inc., Durham, N.C.). An absorbance reading of >0.70 was considered indicative of a positive reaction (11).

Western immunoblot analysis. Western immunoblotting was performed as previously described (1, 2) to verify the reactivity of sera experimentally infected with E. canis with the rMAP2s of E. canis and E. chaffeensis. Briefly, E. canis rMAP2 was dissolved in 3x sample buffer containing 7.5% ß-mercaptoethanol and heat denatured at 100°C for 3 min prior to electrophoresis on SDS-10% polyacrylamide gels. E. chaffeensis rMAP2 was dissolved in 3x sample buffer without ß-mercaptoethanol and was not heat denatured. Serum samples from dogs experimentally infected with E. canis were used at a dilution of 1/300 and reacted with rMAP2 of E. canis or E. chaffeensis. Noninfected human or dog serum was used as a negative control at a dilution of 1/300. The secondary antibody, HRP-conjugated goat anti-human or rabbit anti-dog immunoglobulin G (Sigma Chemical Co.), was used at a dilution of 1/15,000. The bound antibody was visualized by chemiluminescence using hyperfilm (Amersham International plc).


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Sequencing and analysis of the map2 gene. From comparing sequence data, it was found that geographic isolates within each species differed at only a single nucleotide position. The map2 genes from three human isolates of E. chaffeensis (Arkansas [GenBank accession no. AF117731], Osceola, and Liberty) contained a thymine at position 243, while the Wakulla isolate had a cytosine at this position. The map2 genes from three canine cases of E. chaffeensis infection (Jack, Cherokee, and Shasta) were identical to those of the Arkansas, Osceola, and Liberty strains of the human isolate. A thymine was detected at position 549 in the Virginia and North Carolina E. canis isolates (Jellybean and DJ, respectively), while the Oklahoma (GenBank accession no. AF117730), Israel no. 611, and Florida strains had a cytosine at this position. None of the nucleotide substitutions observed within either species translated into any differences in amino acid sequences. A comparison of the MAP2 amino acid sequences of E. canis (Oklahoma) and E. chaffeensis (Arkansas) revealed that there is a 79% identity between the two proteins (Fig. 1). However, a 19-amino-acid peptide sequence of higher heterology between the two species was also identified (Fig. 1).



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 1. Alignment of amino acid sequences of E. canis (can) and E. chaffeensis (chaff) MAP2 proteins. Dashes, identical amino acids; boldface, region predicted to be an antigenic determinant by the PEPTIDE STRUCTURE program (GCG) (12).

 
Southern blot analysis. Genomic DNA of E. canis and E. chaffeensis was cut with restriction enzymes VspI, BamHI, ClaI, and EcoRI. When digested genomic DNA was hybridized with a DIG-labeled species-specific map2 probe, single bands of 2.5, 12.2, and 5.0 kb were recognized in E. chaffeensis DNA digested with VspI, BamHI, and ClaI, respectively (Fig. 2). Similarly, single bands measuring 0.5, 12.2, and 11.0 kb were recognized by using the species-specific probe when E. canis DNA was digested with VspI, BamHI, and ClaI, respectively (Fig. 2). A single hybridized band was expected if a single-copy gene encoded the MAP2. These enzymes do not cut within the known sequence of the map2 gene. EcoRI digestion generated two fragments in both E. chaffeensis (12.2 and 3.9 kb) and E. canis (6.1 and 1.5 kb) (Fig. 2). This was also expected if a single-copy gene encodes the MAP2, since one internal EcoRI site is present in each of the genes.



View larger version (47K):
[in this window]
[in a new window]
  		FIG. 2. Genomic Southern blot analysis of E. chaffeensis (left) and E. canis (right) DNA with DIG-labeled map2 species-specific gene probes. Lanes map2, map2 gene amplified by PCR with species-specific primers (positive control); lanes DH82, uninfected DH82 macrophage cell DNA (negative control) cut with VspI. The other lanes show genomic DNA of E. chaffeensis or E. canis cut with BamHI, VspI, EcoRI, and ClaI. Numbers on the left of each panel indicate molecular sizes based on a 1-kb ladder (Invitrogen).

 
Cross-reactivity analysis. All of the 18 serum samples from dogs experimentally infected with E. canis reacted strongly with the rMAP2 of both E. canis and E. chaffeensis in ELISA, and the immune serum from the dog experimentally infected with E. canis clearly recognized the E. canis and E. chaffeensis rMAP2 on Western immunoblot analysis (Fig. 3). E. canis IFA-negative control samples did not react with the rMAP2 of E. canis or E. chaffeensis in either the ELISA or Western blot analysis.



View larger version (52K):
[in this window]
[in a new window]
  		FIG. 3. Western blot analysis of cross-reactivity between serum from an E. canis-infected dog with rMAP2s of E. canis and E. chaffeensis. Lanes 1 to 3 (counting from the left), E. canis rMAP2 reacted with the antihistidine control (lane 1), IFA-negative canine serum from an uninfected animal used as a negative control (lane 2), and IFA-positive immune serum from an experimentally infected dog used as a positive control (lane 3); lane 4, E. chaffeensis rMAP2 reacted with E. canis-infected serum. Molecular size standards (in kilodaltons) are given on the left.

 

   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
We have further characterized the MAP2 of E. chaffeensis and E. canis. Species-specific DIG-labeled map2 probes hybridized to the map2 genes in the E. chaffeensis and E. canis genomes. Southern blot analyses were performed under low-stringency conditions to ensure that the species-specific probes would identify all possible copies of the map2 gene, despite any sequence differences in the copies. The hybridization patterns observed using each restriction enzyme suggest that, like the map2 of E. ruminantium (4) and the msp5 of A. marginale (17), the map2 genes of E. chaffeensis and E. canis are single-copy genes. Since many organisms use multigene families to produce antigenic diversity, this indicates that there is not likely to be antigenic variation of map2 among different strains of the organism.

The conservation of the map2 gene was evaluated by comparing nucleotide sequences from seven geographically different isolates of E. chaffeensis and five isolates of E. canis. The map2 genes were highly conserved among the various isolates of each respective bacterial species. In fact, translated amino acid sequences for all isolates within each species were identical. The MAP2 proteins of E. ruminantium (4) and the MSP5 proteins of A. marginale (17) were also highly conserved among the various isolates within their respective species, suggesting that this protein may be important for the metabolic function and sustainment of the microorganisms.

The function of the MAP2s of E. chaffeensis and E. canis is still unknown. The translated amino acid sequence of MAP2 is homologous to that of the SCO2 protein precursor found in Rickettsia prowazekii (3) (E value: 2e-23; accession no. F71663 [Protein Identification Resource database]). The SCO2 protein of R. prowazekii is homologous to a protein located in the mitochondrial inner membrane of mammalian cells that is involved in mitochondrial organization as well as respiration. Defects in SCO2 result in decreased activity in cytochrome oxidase (7, 10). The fact that this function is vital to cell viability may explain why the ortholog of this gene is found in E. canis, E. chaffeensis, A. marginale, and E. ruminantium.

There is a high percentage of identity (79%) between the amino acid sequences of E. canis and E. chaffeensis MAP2s. Because this indicates a high probability of epitope sharing, cross-reactivity experiments were performed. All serum samples from dogs experimentally infected with E. canis contained antibodies that recognized the rMAP2 of E. chaffeensis. Western blot analysis confirmed that the E. canis-infected dog serum reacted strongly with both the E. canis and E. chaffeensis rMAP2 antigens, demonstrating that the rMAP2s of E. canis and E. chaffeensis have shared epitopes.

Previously we reported that the rMAP2 of E. chaffeensis contained structurally dependent epitopes that were destroyed by boiling, SDS, or ß-mercaptoethanol (1). However, this work was done using serum samples from people naturally infected with E. chaffeensis. Subsequently, we reported that, when E. canis rMAP2 and serum from naturally and experimentally infected dogs were used, epitopes on the E. canis rMAP2 were easily identified on Western blots (2). In the present study, rMAP2 from E. chaffeensis was reacted with immune serum from a dog experimentally infected with E. canis. We conclude that there are shared epitopes between rMAP2s of E. canis and E. chaffeensis and that at least some of the epitopes recognized by serum from dogs infected with E. canis are not structurally dependent. Additionally, the immune response in dogs experimentally infected with large numbers of organisms may be of greater magnitude than that in people with natural infections with E. chaffeensis.

A small region in the MAP2 amino acid sequences (positions 32 through 50) of E. canis and E. chaffeensis was predicted to be an antigenic determinant by the PEPTIDE STRUCTURE program (GCG) (12). In addition, these segments are areas of concentrated heterology between the two proteins, with different amino acids in 11 of the 19 positions (42% homology).

In this study, we determined that a highly conserved single-copy gene encodes E. canis and E. chaffeensis MAP2s. The rMAP2s of E. chaffeensis and E. canis can be used for the serodiagnosis of canine ehrlichiosis but failed to serologically distinguish between infections. However, the sensitivity of the rMAP2 would not be affected by geographic location, as we did not detect any genetic variants. Future studies are needed to determine if epitope differences between E. chaffeensis and E. canis MAP2s could be targeted to develop a serologic assay that might rapidly distinguish between E. canis and E. chaffeensis infections. Such a test would be convenient, cost-effective, and useful for clinical diagnosis of ehrlichiosis. The prevalence of E. chaffeensis infection in dogs is currently unknown, and the development of such an assay could be a valuable tool for epidemiological studies to determine the importance of dogs as reservoirs for E. chaffeensis infections.


   ACKNOWLEDGMENTS
 
This work was supported by a grant from the University of Florida, College of Veterinary Medicine, Department of Sponsored Research, UPN 01031471.

We thank Donald J. Forrester, John Harvey, and Patrick Meeus for critical review of the manuscript.


   FOOTNOTES
 
* Corresponding author. Mailing address: Clinical Pathology Service, College of Veterinary Medicine, University of Florida, P.O. Box 100103, Gainesville, FL 32610. Phone: (352) 392-4700, ext. 5858. Fax: (352) 392-2938. E-mail: allemanr{at}mail.vetmed.ufl.edu. Back

{ddagger} University of Florida College of Veterinary Medicine Journal Series number 631. Back

{dagger} Present address: Department of Oral Biology, Center for Molecular Microbiology, University of Florida, Gainesville, FL 32610-0424. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Alleman, A. R., A. F. Barbet, M. V. Bowie, H. L. Sorenson, S. Wong, and M. Bélanger. 2000. Expression of a gene encoding the major antigenic protein 2 homologue of Ehrlichia chaffeensis and potential application for serodiagnosis. J. Clin. Microbiol. 38:3705-3709.[Abstract/Free Full Text]
  2. Alleman, A. R., L. J. McSherry, A. F. Barbet, E. B. Breitschwerdt, H. L. Sorenson, M. V. Bowie, and M. Bélanger. 2001. The recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool. J. Clin. Microbiol. 39:2494-2499.[Abstract/Free Full Text]
  3. Andersson, S. G., A. Zomorodipour, J. O. Andersson, T. Sicheritz-Ponten, U. C. Alsmark, R. M. Podowski, A. K. Naslund, A. S. Eriksson, H. H. Winkler, and C. G. Kurland. 1998. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396:133-140.[CrossRef][Medline]
  4. Bowie, M. V., G. R. Reddy, S. M. Semu, S. M. Mahan, and A. F. Barbet. 1999. Potential value of major antigenic protein 2 for serological diagnosis of heartwater and related ehrlichial infections. Clin. Diagn. Lab. Immunol. 6:209-215.[Abstract/Free Full Text]
  5. Breitschwerdt, E. B., B. C. Hegarty, and S. J. Hancock. 1998. Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii. J. Clin. Microbiol. 36:2645-2651.[Abstract/Free Full Text]
  6. Breitschwerdt, E. B., B. C. Hegarty, and S. I. Hancock. 1998. Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains. Antimicrob. Agents Chemother. 42:362-368.[Abstract/Free Full Text]
  7. Buchwald, P., G. Krummeck, and G. Rodel. 1991. Immunological identification of yeast SCO1 protein as a component of the inner mitochondrial membrane. Mol. Gen. Genet. 229:413-420.[CrossRef][Medline]
  8. Chen, S. M., V. L. Popov, H. Feng, and D. H. Walker. 1996. Analysis and ultrastructural localization of Ehrlichia chaffeensis proteins with monoclonal antibodies. Am. J. Trop. Med. Hyg. 54:405-412.
  9. Dawson, J. E., D. E. Stallnecht, E. W. Howerth, C. Warner, K. Biggie, W. R. Davidson, J. M. Lockhart, V. F. Nettles, J. G. Olson, and J. E. Childs. 1994. Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J. Clin. Microbiol. 32:2725-2728.[Abstract/Free Full Text]
  10. Glerum, D. M., A. Shtanko, and A. Tzagoloff. 1996. SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae. J. Biol. Chem. 271:20531-20535.[Abstract/Free Full Text]
  11. Harrus, S., A. R. Alleman, H. Bark, S. M. Mahan, and T. Waner. 2002. Comparison of three enzyme-linked immunosorbent assays with the indirect immunofluorescent antibody test for the diagnosis of canine infection with Ehrlichia canis. Vet. Microbiol. 86:361-368.[CrossRef][Medline]
  12. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci. 4:181-186.[Abstract/Free Full Text]
  13. Keysary, A., T. Waner, M. Rosner, C. K. Warner, J. E. Dawson, R. Zass, K. L. Biggie, and S. Harrus. 1996. The first isolation, in vitro propagation, and genetic characterization of Ehrlichia canis in Israel. Vet. Parasitol. 62:331-340.[CrossRef][Medline]
  14. Kordick, S. K., E. B. Breitschwerdt, B. C. Hegarty, K. L. Southwick, C. M. Colitz, S. I. Hancock, J. M. Bradley, R. Rumbough, T. McPherson, and J. N. MacCormack. 1999. Coinfection with multiple tick-borne pathogens in a walker hound kennel in North Carolina. 37:2631-2638.
  15. McBride, J. W., R. E. Cortsvet, E. B. Brietschwerdt, and D. H. Walker. 2001. Immunodiagnosis of Ehrlichia canis infection with recombinant proteins. J. Clin. Microbiol. 39:315-322.[Abstract/Free Full Text]
  16. Ohashi, N., A. Unver, N. Zhi, and Y. Rikihisa. 1998. Cloning and characterization of multigenes encoding the immunodominant 30-kilodalton major outer membrane proteins of Ehrlichia canis and application of the recombinant protein for serodiagnosis. J. Clin. Microbiol. 36:2671-2680.[Abstract/Free Full Text]
  17. Visser, E. S., T. C. McGuire, G. H. Palmer, W. C. Davis, V. Shkap, E. Pipano, and D. P. Knowles. 1992. The Anaplasma marginale msp5 gene encodes a 19-kilodalton protein conserved in all recognized Anaplasma species. Infect. Immun. 60:5139-5144.[Abstract/Free Full Text]
  18. Walker, J. S., J. D. Rundquist, R. Taylor, B. L. Wilson, M. R. Andrews, J. Barck, A. L. Hogge, D. L. Huxoll, P. K. Hildebrandt, and R. M. Nims. 1970. Clinical and clinicopathologic findings in tropical canine pancytopenia. J. Am. Vet. Med. Assoc. 157:43-55.[Medline]
  19. Waner, T., C. Strenger, and A. Keysary. 2000. Comparison of clinical-based ELISA test kit with the immunofluorescence test for the assay of Ehrlichia canis antibodies in dogs. J. Vet. Diagn. Investig. 12:240-244.[Abstract/Free Full Text]
  20. Waner, T., S. Harrus, F. Jongejan, H. Bark, A. Keysary, and A. W. C. A. Cornelissen. 2001. Significance of serological testing for ehrlichial diseases in dogs with special emphasis on the diagnosis of ehrlichiosis caused by Ehrlichia canis. Vet. Parasitol. 95:1-15.[CrossRef][Medline]
  21. Yu, X., P. Croquet-Valdes, L. C. Cullman, and D. Walker. 1996. The recombinant 120-kilodalton protein of Ehrlichia chaffeensis, a potential diagnostic tool. J. Clin. Microbiol. 34:2853-2855.[Abstract]
  22. Yu, X., J. W. McBride, and D. Walker. 1999. Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis. J. Clin. Microbiol. 37:1137-1143.[Abstract/Free Full Text]
  23. Yu, X., J. W. McBride, C. M. Diaz, and D. Walker. 2000. Molecular cloning and characterization of the 120-kilodalton protein gene of Ehrlichia canis and application of the recombinant 120-kilodalton protein for serodiagnosis of canine ehrlichiosis. J. Clin. Microbiol. 38:369-374.[Abstract/Free Full Text]

Clinical and Diagnostic Laboratory Immunology, July 2003, p. 520-524, Vol. 10, No. 4
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.4.520-524.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knowles, T. T.
Right arrow Articles by Bélanger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knowles, T. T.
Right arrow Articles by Bélanger, M.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS